NEXUS AG (NXU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:NXU - DE0005220909 - Common Stock
71.3 EUR
0 (0%)
We assign a fundamental rating of 7 out of 10 to NXU. NXU was compared to 11 industry peers in the Health Care Technology industry. NXU gets an excellent profitability rating and is at the same time showing great financial health properties. NXU shows excellent growth, but is valued quite expensive already. These ratings could make NXU a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
In the past year NXU was profitable.
NXU had a positive operating cash flow in the past year.
NXU had positive earnings in each of the past 5 years.
In the past 5 years NXU always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of NXU (6.93%) is better than 63.64% of its industry peers.
NXU's Return On Equity of 11.27% is fine compared to the rest of the industry. NXU outperforms 72.73% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.35%, NXU is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NXU is in line with the industry average of 8.99%.
The 3 year average ROIC (7.85%) for NXU is below the current ROIC(8.35%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.93% | ||
| ROE | 11.27% | ||
| ROIC | 8.35% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
1.3 Margins
The Profit Margin of NXU (12.11%) is better than 81.82% of its industry peers.
NXU's Profit Margin has improved in the last couple of years.
The Operating Margin of NXU (15.41%) is better than 81.82% of its industry peers.
In the last couple of years the Operating Margin of NXU has grown nicely.
NXU's Gross Margin of 84.70% is fine compared to the rest of the industry. NXU outperforms 72.73% of its industry peers.
In the last couple of years the Gross Margin of NXU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.41% | ||
| PM (TTM) | 12.11% | ||
| GM | 84.7% |
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
NXU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for NXU remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NXU has more shares outstanding
Compared to 1 year ago, NXU has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.57 indicates that NXU is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.57, NXU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Debt to FCF ratio of NXU is 0.34, which is an excellent value as it means it would take NXU, only 0.34 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.34, NXU belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that NXU is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.05, NXU belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.34 | ||
| Altman-Z | 5.57 |
ROIC/WACC1.15
WACC7.28%
2.3 Liquidity
NXU has a Current Ratio of 2.13. This indicates that NXU is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NXU (2.13) is better than 81.82% of its industry peers.
NXU has a Quick Ratio of 2.08. This indicates that NXU is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.08, NXU belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.08 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.97% over the past year.
Measured over the past years, NXU shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.97% on average per year.
NXU shows a small growth in Revenue. In the last year, the Revenue has grown by 7.41%.
Measured over the past years, NXU shows a quite strong growth in Revenue. The Revenue has been growing by 12.11% on average per year.
EPS 1Y (TTM)26.97%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%-3.19%
Revenue 1Y (TTM)7.41%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%9.14%
3.2 Future
The Earnings Per Share is expected to grow by 15.50% on average over the next years. This is quite good.
NXU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.47% yearly.
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 36.19, the valuation of NXU can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as NXU.
NXU's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.45.
The Price/Forward Earnings ratio is 32.28, which means the current valuation is very expensive for NXU.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NXU is on the same level as its industry peers.
NXU's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 34.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.19 | ||
| Fwd PE | 32.28 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NXU is valued a bit more expensive than 63.64% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NXU is valued a bit cheaper than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.8 | ||
| EV/EBITDA | 16.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of NXU may justify a higher PE ratio.
A more expensive valuation may be justified as NXU's earnings are expected to grow with 15.50% in the coming years.
PEG (NY)2.48
PEG (5Y)1.73
EPS Next 2Y14.95%
EPS Next 3Y15.5%
5. Dividend
5.1 Amount
With a yearly dividend of 0.32%, NXU is not a good candidate for dividend investing.
NXU's Dividend Yield is comparable with the industry average which is at 3.62.
Compared to an average S&P500 Dividend Yield of 2.45, NXU's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
5.2 History
The dividend of NXU has a limited annual growth rate of 2.17%.
Dividend Growth(5Y)2.17%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
NXU pays out 11.69% of its income as dividend. This is a sustainable payout ratio.
NXU's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP11.69%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
FRA:NXU (11/21/2025, 7:00:00 PM)
71.3
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners45.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.23B
Revenue(TTM)280.33M
Net Income(TTM)33.95M
Analysts45.71
Price Target71.4 (0.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
Yearly Dividend0.22
Dividend Growth(5Y)2.17%
DP11.69%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.19 | ||
| Fwd PE | 32.28 | ||
| P/S | 4.39 | ||
| P/FCF | 21.8 | ||
| P/OCF | 18.35 | ||
| P/B | 4.09 | ||
| P/tB | 17.81 | ||
| EV/EBITDA | 16.24 |
EPS(TTM)1.97
EY2.76%
EPS(NY)2.21
Fwd EY3.1%
FCF(TTM)3.27
FCFY4.59%
OCF(TTM)3.88
OCFY5.45%
SpS16.23
BVpS17.45
TBVpS4
PEG (NY)2.48
PEG (5Y)1.73
Graham Number27.81
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.93% | ||
| ROE | 11.27% | ||
| ROCE | 11.14% | ||
| ROIC | 8.35% | ||
| ROICexc | 12.84% | ||
| ROICexgc | 162.09% | ||
| OM | 15.41% | ||
| PM (TTM) | 12.11% | ||
| GM | 84.7% | ||
| FCFM | 20.15% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
ROICexc(3y)12.19%
ROICexc(5y)11.45%
ROICexgc(3y)147.03%
ROICexgc(5y)150.84%
ROCE(3y)10.47%
ROCE(5y)10.94%
ROICexgc growth 3Y-0.23%
ROICexgc growth 5Y4.33%
ROICexc growth 3Y3.77%
ROICexc growth 5Y2.6%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
F-Score6
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.34 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 53.69% | ||
| Cap/Sales | 3.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.6% | ||
| Profit Quality | 166.39% | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.08 | ||
| Altman-Z | 5.57 |
F-Score6
WACC7.28%
ROIC/WACC1.15
Cap/Depr(3y)46.55%
Cap/Depr(5y)41.01%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.36%
Profit Quality(3y)122.34%
Profit Quality(5y)137.83%
High Growth Momentum
Growth
EPS 1Y (TTM)26.97%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%-3.19%
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.41%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%9.14%
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
EBIT growth 1Y16.23%
EBIT growth 3Y16.4%
EBIT growth 5Y15.93%
EBIT Next Year66.24%
EBIT Next 3Y29.63%
EBIT Next 5YN/A
FCF growth 1Y141.55%
FCF growth 3Y16.82%
FCF growth 5Y17.03%
OCF growth 1Y109.22%
OCF growth 3Y17.98%
OCF growth 5Y15.93%
NEXUS AG / NXU.DE FAQ
Can you provide the ChartMill fundamental rating for NEXUS AG?
ChartMill assigns a fundamental rating of 7 / 10 to NXU.DE.
Can you provide the valuation status for NEXUS AG?
ChartMill assigns a valuation rating of 3 / 10 to NEXUS AG (NXU.DE). This can be considered as Overvalued.
Can you provide the profitability details for NEXUS AG?
NEXUS AG (NXU.DE) has a profitability rating of 8 / 10.
What is the valuation of NEXUS AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NEXUS AG (NXU.DE) is 36.19 and the Price/Book (PB) ratio is 4.09.
Can you provide the dividend sustainability for NXU stock?
The dividend rating of NEXUS AG (NXU.DE) is 4 / 10 and the dividend payout ratio is 11.69%.